Nephrogen
Summer 2020 · Active
Curative gene therapies for kidney diseases
Location: New York, US
Founded: 2022
Team size: 1
Industries:
About
Nephrogen is a biotech company developing curative gene therapies for kidney and pancreatic diseases. Kidney disease affects 1 in 7 Americans (~50 million people), has no cure, and accounts for nearly 10% of the Medicare budget.
Founders
Demetri MaximFounder
Stanford B.S. '20 (Biology), Founder of Nephrogen